Business Segments · Intangible asset impairment charge
Business Segments — Intangible asset impairment charge
Year-over-year, this metric declined by 100.0%, from $379M to $0. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026May 5, 2026
Rolls up toImpairment Charges
How to read this metric
An increase signals that previous investments or acquisitions are underperforming or have lost commercial viability.
Detailed definition
Non-cash charges recognized when the carrying value of an intangible asset, such as acquired intellectual property or li...
Peer comparison
Commonly reported by peers as 'Impairment of Intangible Assets'.
Metric ID:
vrtx_segment_pharmaceuticals_intangible_asset_impairment_chargeHistorical Data
13 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $379M | $0 | $0 | $0 | $0 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |
Range$0 – $379M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's business segments — intangible asset impairment charge?
- Vertex Pharmaceuticals (VRTX) reported business segments — intangible asset impairment charge of $0 in Q1 2026.
- How has Vertex Pharmaceuticals's business segments — intangible asset impairment charge changed year-over-year?
- Vertex Pharmaceuticals's business segments — intangible asset impairment charge decreased by 100.0% year-over-year, from $379M to $0.
- What does business segments — intangible asset impairment charge mean?
- A write-down in the value of intangible assets like patents or acquired drug rights.